Metropolitan Life Insurance Company (MetLife)’s Sensient Technologies SXT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,198
| Closed | -$152K | – | 1876 |
|
|
2024
Q1 | $152K | Sell |
2,198
-227
| -9% | -$14.7K | 0.01% | 828 |
|
|
2023
Q4 | $160K | Hold |
2,425
| – | – | 0.01% | 847 |
|
|
2023
Q3 | $142K | Buy |
2,425
+123
| +5% | +$7.75K | 0.01% | 841 |
|
|
2023
Q2 | $164K | Buy |
2,302
+62
| +3% | +$4.6K | 0.01% | 765 |
|
|
2023
Q1 | $171K | Sell |
2,240
-340
| -13% | -$25.3K | 0.01% | 726 |
|
|
2022
Q4 | $188K | Buy |
2,580
+83
| +3% | +$5.95K | 0.01% | 742 |
|
|
2022
Q3 | $173K | Hold |
2,497
| – | – | 0.01% | 728 |
|
|
2022
Q2 | $201K | Sell |
2,497
-143
| -5% | -$11.9K | 0.01% | 690 |
|
|
2022
Q1 | $222K | Sell |
2,640
-14,617
| -85% | -$1.23M | 0.01% | 769 |
|
|
2021
Q4 | $1.73M | Sell |
17,257
-620
| -3% | -$60.3K | 0.02% | 619 |
|
|
2021
Q3 | $1.63M | Sell |
17,877
-1,225
| -6% | -$107K | 0.02% | 623 |
|
|
2021
Q2 | $1.65M | Buy |
19,102
+713
| +4% | +$60.4K | 0.02% | 643 |
|
|
2021
Q1 | $1.43M | Sell |
18,389
-120
| -0.6% | -$9.22K | 0.02% | 721 |
|
|
2020
Q4 | $1.37M | Sell |
18,509
-894
| -5% | -$62.4K | 0.02% | 678 |
|
|
2020
Q3 | $1.12M | Sell |
19,403
-635
| -3% | -$35K | 0.02% | 677 |
|
|
2020
Q2 | $1.05M | Sell |
20,038
-2,894
| -13% | -$137K | 0.02% | 716 |
|
|
2020
Q1 | $998K | Sell |
22,932
-531
| -2% | -$29.3K | 0.02% | 680 |
|
|
2019
Q4 | $1.55M | Sell |
23,463
-1,078
| -4% | -$69K | 0.02% | 676 |
|
|
2019
Q3 | $1.68M | Sell |
24,541
-287
| -1% | -$19.6K | 0.03% | 580 |
|
|
2019
Q2 | $1.82M | Buy |
24,828
+9
| +0% | +$636 | 0.03% | 565 |
|
|
2019
Q1 | $1.68M | Buy |
24,819
+1
| +0% | +$63 | 0.03% | 579 |
|
|
2018
Q4 | $1.39M | Buy |
24,818
+30
| +0.1% | +$1.96K | 0.03% | 617 |
|
|
2018
Q3 | $1.9M | Sell |
24,788
-38
| -0.2% | -$2.71K | 0.03% | 558 |
|
|
2018
Q2 | $1.78M | Buy |
24,826
+456
| +2% | +$31.6K | 0.03% | 589 |
|
|
2018
Q1 | $1.72M | Sell |
24,370
-640
| -3% | -$46.1K | 0.02% | 624 |
|
|
2017
Q4 | $1.83M | Sell |
25,010
-45,022
| -64% | -$3.43M | 0.02% | 600 |
|
|
2017
Q3 | $5.39M | Sell |
70,032
-760
| -1% | -$57.6K | 0.03% | 543 |
|
|
2017
Q2 | $5.7M | Buy |
70,792
+567
| +0.8% | +$45.8K | 0.04% | 491 |
|
|
2017
Q1 | $5.57M | Sell |
70,225
-272
| -0.4% | -$21.4K | 0.04% | 524 |
|
|
2016
Q4 | $5.54M | Sell |
70,497
-2,146
| -3% | -$164K | 0.04% | 503 |
|
|
2016
Q3 | $5.51M | Sell |
72,643
-970
| -1% | -$71.2K | 0.04% | 472 |
|
|
2016
Q2 | $5.23M | Buy |
73,613
+1,341
| +2% | +$90.8K | 0.04% | 500 |
|
|
2016
Q1 | $4.59M | Buy |
72,272
+812
| +1% | +$47.8K | 0.04% | 554 |
|
|
2015
Q4 | $4.49M | Buy |
71,460
+376
| +0.5% | +$24.3K | 0.03% | 551 |
|
|
2015
Q3 | $4.36M | Sell |
71,084
-905
| -1% | -$59.5K | 0.03% | 570 |
|
|
2015
Q2 | $4.92M | Sell |
71,989
-6,500
| -8% | -$441K | 0.03% | 556 |
|
|
2015
Q1 | $5.41M | Buy |
78,489
+931
| +1% | +$58.1K | 0.04% | 488 |
|
|
2014
Q4 | $4.68M | Buy |
77,558
+305
| +0.4% | +$17.5K | 0.03% | 572 |
|
|
2014
Q3 | $4.04M | Sell |
77,253
-730
| -0.9% | -$39.8K | 0.03% | 615 |
|
|
2014
Q2 | $4.34M | Sell |
77,983
-3,472
| -4% | -$189K | 0.03% | 610 |
|
|
2014
Q1 | $4.59M | Buy |
81,455
+727
| +0.9% | +$37.4K | 0.03% | 572 |
|
|
2013
Q4 | $3.92M | Buy |
80,728
+1,959
| +2% | +$97.6K | 0.03% | 631 |
|
|
2013
Q3 | $3.77M | Buy |
78,769
+503
| +0.6% | +$22K | 0.03% | 615 |
|
|
2013
Q2 | $3.17M | Buy |
+78,266
| New | +$3.1M | 0.03% | 664 |
|
Other funds holding SXT
WPL
CIP
SCM
Metropolitan Life Insurance Company (MetLife)'s SXT Position: Q2 2024 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Sensient Technologies (SXT) in Q2 2024, closing a stake of 2,198 shares — an estimated $152K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SXT in Q2 2013 and held it in 44 quarters. The position peaked at $5.7M in Q2 2017. 249 funds tracked by Wall St. Rank hold SXT as of Q2 2024.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Sensient Technologies position as of Q2 2024 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,198 Sensient Technologies shares in Q2 2024, an estimated $152K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Sensient Technologies in Q2 2013 and held it in 44 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Sensient Technologies position peaked at $5.7M in Q2 2017.
- 249 funds tracked by Wall St. Rank held Sensient Technologies as of Q2 2024.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.